# Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders

> **NCT00001238** · — · RECRUITING · sponsor: **National Cancer Institute (NCI)** · enrollment: 5000 (estimated)

## Conditions studied

- Kidney Cancer
- Urologic Malignant Disorders
- Renal Cell Carcinoma
- Familial Renal Cancer (FRC)
- Clear Cell Renal Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00001238
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 1990-12-05
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 5000 (ESTIMATED)
- **Last updated:** 2026-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001238

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001238, "Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT00001238. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*